A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET
Camurus AB · Gastro-enteropancreatic Neuroendocrine Tumor
Phase 3
Active, not recruiting
332
2026-07
Industry sponsor intelligence
Camurus ABClinical Pipeline.
Lead-sponsor view of Camurus AB's indexed peptide studies, development phases, active programs, completed work and recent registry changes.
- Total
- 5
- Recruiting
- 1
- Active
- 2
- Completed
- 2
- Results posted
- 1
- Avg enrollment
- 153
Pipeline overview
Programs by phase and activity.
Velocity
Camurus AB trials by start year
Study start year · indexed snapshot
Development
Trials by phase
5phase labels
Early Phase 10
Phase 10
Phase 21
Phase 34
Phase 40
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Octreotide → | 5 | 0 | 1 | 4 | 0 | 3 |
| Lanreotide → | 1 | 0 | 0 | 1 | 0 | 1 |
Active peptide trials
In motion now.
NCT IDStudyPhase / statusEnrollmentUpdated
An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly
Camurus AB · Acromegaly
Not applicable
Recruiting
200
2026-06
A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD
Camurus AB · Polycystic Liver Disease
Phase 2 / Phase 3
Active, not recruiting
71
2026-06
Completed trials
Finished registry records.
NCT IDStudyPhase / statusEnrollmentUpdated
A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
Camurus AB · Acromegaly
Phase 3
Completed
135
2025-12
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
Camurus AB · Acromegaly
Phase 3
Completed
72
2024-04
Search sponsor records
All Camurus AB studies.
This page groups studies where Camurus AB is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
5 matching studies
Last registry update first
Recent updates
Latest registry movement.
NCT05050942A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NETJul 28, 2026NCT07583563An Observational Study of Octreotide Subcutaneous Depot in Patients With AcromegalyJun 30, 2026NCT05281328A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLDJun 1, 2026NCT04125836A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With AcromegalyDec 22, 2025NCT04076462A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With AcromegalyApr 25, 2024